Hospital
Curators of the University of Missouri
Curators of the University of Missouri was paid $135.88M by Medicaid between Jan 2018 and Dec 2024, across 413 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 15% of everything it billed.
33Billing provider infoCURATORS OF THE UNIVERSITY OF MISSOURI
COLUMBIA, MO 65212
COLUMBIA, MO 65212
33aNPI1699769901assigned 09/01/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$135.88M
24GClaims1,446,664
24DCodes billed413
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#2 of 74
Median peer was paid$4.44M
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 181,493 | $33.33M | |
| 2019 | 153,422 | $32.95M | |
| 2020 | 118,876 | $13.14M | |
| 2021 | 165,525 | $5.14M | |
| 2022 | 230,443 | $11.30M | |
| 2023 | 316,772 | $19.54M | |
| 2024incomplete | 280,133 | $20.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 15% | 351,716 | 322,677 | $20.16M |
| X4011 | State-specific procedure code | 7.3% | 33,321 | 30,869 | $9.91M |
| Y7506 | 7.1% | 11,733 | 8,196 | $9.63M | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.2% | 51,217 | 49,159 | $8.37M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.9% | 110,962 | 94,896 | $7.96M |
| X4003 | 5.7% | 119,984 | 108,466 | $7.81M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.9% | 30,196 | 28,882 | $6.73M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 20,938 | 19,375 | $5.53M |
| 80053 | Comprehensive metabolic panel | 3.6% | 87,916 | 76,930 | $4.89M |
| G0378 | Hospital observation service, per hour | 2.8% | 7,649 | 6,647 | $3.85M |
| X4006 | 2.2% | 6,851 | 5,434 | $2.97M | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 65,685 | 61,455 | $2.78M |
401 more codes
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1.9% | 25,967 | $2.62M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.9% | 7,729 | $2.59M |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1.8% | 18,437 | $2.46M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 24,636 | $1.89M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.4% | 2,642 | $1.89M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 15,995 | $1.80M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 12,795 | $1.74M |
| 81001 | 1.2% | 13,643 | $1.64M | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.1% | 10,785 | $1.48M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 847 | $1.19M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 6,601 | $1.13M |
| 76818 | <1% | 6,502 | $1.05M | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,827 | $992K |
| 88304 | <1% | 493 | $854K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,185 | $703K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 7,638 | $695K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,347 | $680K |
| 93325 | <1% | 1,443 | $622K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,237 | $619K |
| J3490 | Unclassified drugs | <1% | 5,478 | $530K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 4,526 | $496K |
| 59025 | Fetal non-stress test | <1% | 3,055 | $468K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 6,215 | $462K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,729 | $450K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,383 | $437K |
| 84703 | <1% | 1,517 | $415K | |
| 76820 | <1% | 2,025 | $381K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,002 | $350K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,341 | $337K |
| 87428 | <1% | 15,645 | $332K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13,497 | $328K |
| 92567 | <1% | 8,334 | $319K | |
| 87081 | <1% | 5,100 | $317K | |
| 84484 | <1% | 8,129 | $309K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 953 | $308K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 535 | $301K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 17,770 | $291K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 121 | $290K |
| 84439 | <1% | 5,429 | $286K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,179 | $278K |
| 93321 | <1% | 460 | $275K | |
| 83690 | <1% | 3,590 | $247K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 3,503 | $243K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 619 | $234K |
| 94060 | <1% | 1,295 | $217K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,228 | $208K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,387 | $187K |
| 81003 | <1% | 5,598 | $182K | |
| 94010 | <1% | 1,683 | $181K | |
| 76770 | <1% | 1,636 | $179K | |
| 73630 | <1% | 4,381 | $174K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,076 | $172K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,513 | $168K |
| 72082 | <1% | 1,964 | $167K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,532 | $166K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,642 | $158K |
| A0425 | Ground mileage, per statute mile | <1% | 5,425 | $158K |
| 92060 | <1% | 5,497 | $153K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 619 | $144K |
| 92134 | <1% | 6,063 | $142K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 2,769 | $138K |
| 92579 | <1% | 1,257 | $131K | |
| 76000 | <1% | 42 | $125K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 727 | $124K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 6,405 | $119K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 310 | $113K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,082 | $113K |
| 74018 | <1% | 1,728 | $111K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 12,941 | $109K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,265 | $104K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 1,889 | $103K |
| 85610 | <1% | 3,256 | $103K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 512 | $103K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 82 | $99K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 587 | $97K |
| G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 516 | $96K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,001 | $95K |
| J0475 | Injection, baclofen, 10 mg | <1% | 237 | $93K |
| 95816 | <1% | 307 | $92K | |
| 93304 | <1% | 188 | $90K | |
| 76813 | <1% | 1,053 | $89K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,420 | $87K |
| 85652 | <1% | 1,171 | $85K | |
| 64642 | <1% | 272 | $84K | |
| 82728 | <1% | 3,050 | $81K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,424 | $80K |
| 77072 | <1% | 713 | $79K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 485 | $78K |
| 54161 | <1% | 56 | $76K | |
| 86900 | <1% | 1,569 | $75K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 699 | $74K |
| 80061 | Lipid panel | <1% | 3,325 | $74K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,332 | $72K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 10,159 | $72K |
| 73610 | <1% | 700 | $70K | |
| 82607 | <1% | 2,373 | $69K | |
| 83970 | <1% | 1,955 | $68K | |
| 83550 | <1% | 2,236 | $68K | |
| 77386 | <1% | 233 | $66K | |
| 83540 | <1% | 2,263 | $66K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,884 | $62K |
| 85730 | <1% | 707 | $61K | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 1,063 | $61K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,394 | $61K |
| 85046 | <1% | 839 | $59K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 689 | $57K |
| 92083 | <1% | 1,130 | $54K | |
| 86850 | <1% | 2,168 | $54K | |
| 83520 | <1% | 246 | $53K | |
| 62370 | <1% | 728 | $53K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 526 | $52K |
| 86003 | <1% | 1,769 | $52K | |
| 36591 | <1% | 4,079 | $52K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 509 | $52K |
| 84305 | <1% | 369 | $52K | |
| 92557 | <1% | 750 | $50K | |
| 82397 | <1% | 427 | $49K | |
| 20611 | <1% | 407 | $48K | |
| 72100 | <1% | 1,175 | $48K | |
| 77336 | <1% | 656 | $47K | |
| 86140 | <1% | 435 | $47K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 443 | $46K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,110 | $45K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,993 | $42K |
| 92523 | <1% | 344 | $42K | |
| 84425 | <1% | 1,583 | $41K | |
| 87807 | <1% | 414 | $40K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 435 | $37K |
| 73030 | <1% | 1,164 | $36K | |
| 86901 | <1% | 1,569 | $36K | |
| 84630 | <1% | 1,523 | $34K | |
| 64615 | <1% | 524 | $34K | |
| 83735 | <1% | 2,554 | $34K | |
| 86255 | <1% | 320 | $33K | |
| 73564 | <1% | 604 | $33K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,549 | $32K |
| 84100 | <1% | 2,098 | $30K | |
| 87522 | Neg quan hep c or qual rna | <1% | 586 | $29K |
| 74183 | <1% | 165 | $28K | |
| 76825 | <1% | 86 | $27K | |
| 92133 | <1% | 915 | $27K | |
| 92015 | Determination of refractive state | <1% | 2,587 | $26K |
| 82747 | <1% | 327 | $26K | |
| 93320 | <1% | 328 | $26K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,292 | $25K |
| 97166 | <1% | 406 | $25K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 200 | $25K |
| 84702 | <1% | 126 | $24K | |
| 51705 | <1% | 221 | $24K | |
| 86376 | <1% | 414 | $23K | |
| 86800 | <1% | 376 | $23K | |
| J0586 | Injection, abobotulinumtoxina, 5 units | <1% | 16 | $23K |
| 97597 | <1% | 344 | $23K | |
| 86706 | <1% | 699 | $22K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 173 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 588 | $21K |
| 86708 | <1% | 720 | $21K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,841 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 351 | $21K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 172 | $21K |
| 86780 | <1% | 1,490 | $20K | |
| 67311 | <1% | 14 | $20K | |
| 97162 | <1% | 389 | $20K | |
| 90837 | Psychotherapy session, about an hour | <1% | 324 | $20K |
| 73501 | <1% | 550 | $19K | |
| 80081 | <1% | 178 | $19K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 35 | $19K |
| 95886 | <1% | 309 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 504 | $19K |
| 73562 | <1% | 613 | $19K | |
| 87653 | <1% | 263 | $18K | |
| 84163 | <1% | 122 | $18K | |
| 76827 | <1% | 85 | $17K | |
| 82785 | <1% | 824 | $17K | |
| 83880 | <1% | 644 | $17K | |
| 87536 | <1% | 312 | $17K | |
| 31575 | <1% | 244 | $16K | |
| 51798 | <1% | 632 | $15K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 39 | $15K |
| 72170 | <1% | 198 | $14K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 84 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 417 | $14K |
| 86704 | <1% | 240 | $14K | |
| 82105 | <1% | 970 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 145 | $13K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,234 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 189 | $13K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 165 | $13K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 172 | $13K |
| 64635 | <1% | 17 | $13K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 214 | $12K |
| 29075 | <1% | 68 | $12K | |
| 82746 | <1% | 1,381 | $12K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 984 | $12K |
| 70360 | <1% | 53 | $12K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 134 | $12K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 228 | $12K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 38 | $12K |
| 82962 | <1% | 1,484 | $12K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 755 | $12K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 585 | $12K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 204 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 85 | $11K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 416 | $11K |
| 93922 | <1% | 263 | $11K | |
| 85027 | <1% | 1,037 | $11K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 63 | $11K |
| 88307 | <1% | 103 | $10K | |
| 93296 | <1% | 777 | $10K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 989 | $10K |
| 20610 | <1% | 98 | $10K | |
| 92552 | <1% | 96 | $10K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 94 | $10K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 101 | $10K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 118 | $9K |
| 91200 | <1% | 233 | $9K | |
| 17311 | <1% | 29 | $9K | |
| 76801 | <1% | 136 | $8K | |
| 92504 | <1% | 360 | $8K | |
| 95910 | <1% | 45 | $8K | |
| 82172 | <1% | 91 | $8K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 140 | $8K |
| 83883 | <1% | 91 | $8K | |
| 83010 | <1% | 91 | $8K | |
| 87430 | <1% | 15 | $7K | |
| 82977 | <1% | 91 | $7K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 190 | $7K |
| C7901 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service | <1% | 169 | $7K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 86 | $7K |
| 64643 | <1% | 44 | $7K | |
| 62321 | <1% | 25 | $7K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 82 | $7K |
| 0002A | <1% | 462 | $7K | |
| 87902 | <1% | 30 | $7K | |
| 92020 | <1% | 111 | $7K | |
| 82533 | <1% | 28 | $7K | |
| 77073 | <1% | 82 | $7K | |
| 73130 | <1% | 112 | $6K | |
| 80074 | <1% | 66 | $6K | |
| 84446 | <1% | 655 | $6K | |
| 87210 | <1% | 14 | $6K | |
| 84597 | <1% | 659 | $6K | |
| 82950 | <1% | 242 | $6K | |
| 0001A | <1% | 479 | $6K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 198 | $6K |
| 73100 | <1% | 45 | $6K | |
| 86709 | <1% | 116 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 97 | $6K |
| 17110 | <1% | 54 | $6K | |
| 84590 | <1% | 672 | $6K | |
| 87340 | <1% | 467 | $6K | |
| 96130 | <1% | 27 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 50 | $5K |
| 96112 | <1% | 53 | $5K | |
| 82525 | <1% | 611 | $5K | |
| 72141 | <1% | 49 | $5K | |
| 96415 | <1% | 193 | $5K | |
| 90480 | <1% | 282 | $5K | |
| 96411 | <1% | 209 | $5K | |
| 73560 | <1% | 152 | $5K | |
| 92285 | <1% | 223 | $5K | |
| 73110 | <1% | 98 | $5K | |
| D9420 | <1% | 78 | $5K | |
| 77417 | <1% | 29 | $5K | |
| 72110 | <1% | 114 | $5K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 570 | $5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 617 | $5K |
| 92136 | <1% | 83 | $5K | |
| 86364 | <1% | 635 | $4K | |
| 90686 | <1% | 601 | $4K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 40 | $4K |
| 72040 | <1% | 117 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 29 | $4K |
| 92235 | <1% | 43 | $4K | |
| C7900 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service | <1% | 226 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 43 | $4K |
| 83002 | <1% | 15 | $4K | |
| 83001 | <1% | 14 | $4K | |
| 83615 | <1% | 211 | $4K | |
| 96417 | <1% | 138 | $3K | |
| 86258 | <1% | 528 | $3K | |
| 98940 | <1% | 409 | $3K | |
| 52000 | <1% | 25 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 357 | $3K |
| 86592 | <1% | 26 | $3K | |
| 88312 | <1% | 32 | $3K | |
| 81596 | <1% | 18 | $3K | |
| 80305 | <1% | 136 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 118 | $3K |
| 88142 | <1% | 78 | $3K | |
| 92226 | <1% | 434 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 96 | $3K |
| 80076 | <1% | 185 | $3K | |
| 86762 | <1% | 335 | $3K | |
| 92025 | <1% | 106 | $3K | |
| 62323 | <1% | 12 | $3K | |
| 82805 | <1% | 61 | $3K | |
| 83525 | <1% | 14 | $3K | |
| 82784 | <1% | 665 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 396 | $3K |
| 82570 | <1% | 443 | $3K | |
| 83516 | <1% | 93 | $3K | |
| 84550 | <1% | 14 | $2K | |
| 86304 | <1% | 221 | $2K | |
| 95908 | <1% | 19 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 337 | $2K |
| 31579 | <1% | 12 | $2K | |
| 84156 | <1% | 379 | $2K | |
| 82378 | <1% | 187 | $2K | |
| 92556 | <1% | 27 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 247 | $2K |
| 86231 | <1% | 309 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 34 | $2K |
| 83605 | <1% | 297 | $2K | |
| 95885 | <1% | 13 | $2K | |
| 0124A | <1% | 71 | $2K | |
| 11102 | <1% | 13 | $2K | |
| 86381 | <1% | 137 | $2K | |
| 87070 | <1% | 106 | $1K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 339 | $1K |
| 69210 | <1% | 103 | $1K | |
| 86803 | <1% | 129 | $1K | |
| 87186 | <1% | 31 | $1K | |
| 84460 | <1% | 12 | $1K | |
| 82247 | <1% | 12 | $1K | |
| 73070 | <1% | 67 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $1K |
| 0012A | <1% | 136 | $1K | |
| 86360 | <1% | 42 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 19 | $1K |
| 0011A | <1% | 169 | $1K | |
| 94618 | <1% | 27 | $1K | |
| 99242 | <1% | 14 | $1K | |
| 81025 | <1% | 238 | $1K | |
| 86359 | <1% | 42 | $957.74 | |
| 83020 | <1% | 341 | $950.35 | |
| 0072A | <1% | 55 | $880.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 27 | $785.12 |
| X4014 | <1% | 43 | $715.64 | |
| 73140 | <1% | 12 | $705.52 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $690.37 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $683.75 |
| 76642 | <1% | 15 | $633.12 | |
| 96368 | <1% | 17 | $630.76 | |
| 86015 | <1% | 111 | $629.33 | |
| 76942 | <1% | 13 | $627.88 | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 15 | $579.33 |
| 82103 | <1% | 89 | $531.52 | |
| 71250 | <1% | 13 | $510.91 | |
| 86341 | <1% | 32 | $500.60 | |
| 93308 | <1% | 13 | $475.93 | |
| 86480 | <1% | 14 | $446.25 | |
| 0071A | <1% | 212 | $440.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $435.82 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 50 | $377.23 |
| 11721 | <1% | 46 | $293.78 | |
| 80197 | <1% | 113 | $288.12 | |
| 80143 | <1% | 14 | $281.92 | |
| 80179 | <1% | 14 | $281.92 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 40 | $277.12 |
| 82390 | <1% | 62 | $274.56 | |
| 92201 | <1% | 29 | $237.70 | |
| 97804 | <1% | 516 | $237.15 | |
| 0001M | <1% | 30 | $232.29 | |
| 95250 | <1% | 13 | $223.12 | |
| 93297 | <1% | 117 | $213.21 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 42 | $192.84 |
| 73090 | <1% | 13 | $183.51 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 96 | $142.79 |
| 93298 | <1% | 57 | $142.11 | |
| 86580 | <1% | 20 | $122.83 | |
| 73590 | <1% | 13 | $120.23 | |
| 82104 | <1% | 17 | $118.34 | |
| 87077 | <1% | 49 | $114.59 | |
| 82077 | <1% | 13 | $111.88 | |
| 85018 | <1% | 74 | $105.95 | |
| 95874 | <1% | 146 | $105.80 | |
| 90670 | <1% | 14 | $104.86 | |
| 84481 | <1% | 13 | $103.70 | |
| 86008 | <1% | 13 | $93.60 | |
| 27096 | <1% | 35 | $86.19 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 50 | $52.72 |
| 76514 | <1% | 31 | $46.93 | |
| 80069 | <1% | 14 | $46.86 | |
| 84238 | <1% | 14 | $29.25 | |
| 82379 | <1% | 12 | $26.98 | |
| 84403 | <1% | 12 | $20.64 | |
| 84402 | <1% | 12 | $20.37 | |
| 82043 | <1% | 13 | $16.64 | |
| 96376 | <1% | 1,029 | $14.66 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $13.30 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 15 | $1.54 |
| G0008 | Administration of influenza virus vaccine | 0% | 45 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 15 | $0.00 |
| 46600 | 0% | 13 | $0.00 | |
| 00000 | 0% | 45 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 42 | $0.00 |
| D7999 | 0% | 13 | $0.00 | |
| 91320 | 0% | 27 | $0.00 | |
| 84207 | 0% | 12 | $0.00 | |
| C1776 | Joint device (implantable) | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRANSOM, FREDERIC (CEO)
| Provider | Location | Paid |
|---|---|---|
| Curators of the University of Missouri | Jefferson City, MO | $12.09M |
| Curators of the University of Missouri | Columbia, MO | $6.18M |
| Curators of the University of Missouri | Columbia, MO | $3K |
| Curators of the University of Missouri | Columbia, MO | $105.60 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.